Highlights and a hidden hazard--the FDA's new labeling regulations.
Avorn
Jerry
J
Harvard Medical School and Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital, Boston, USA.
Shrank
William
W
D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D011307:Drug Prescriptions; D064420:Drug-Related Side Effects and Adverse Reactions; D033161:Government Regulation; D006801:Humans; D016365:Liability, Legal; D014481:United States; D014486:United States Food and Drug Administration